emactuzumab
Showing 1 - 4 of 4
TGCT Trial in Washington, Baltimore (Emactuzumab, Placebo)
Active, not recruiting
- TGCT
- Emactuzumab
- Placebo
-
Washington, District of Columbia
- +1 more
Sep 23, 2022